On 26 April 2023, the Board of Core Laboratories N.V. approved a cash dividend of $0.01 per share of common stock payable on 30 May 2023 to shareholders of record on 8 May 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.42 USD | -2.18% | +1.43% | +4.30% |
04-25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
04-24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.30% | 864M | |
+16.21% | 17.22B | |
0.00% | 1.37B | |
-10.70% | 2.73B | |
-26.80% | 1.85B | |
-5.20% | 1.13B | |
-6.97% | 1.07B | |
-13.45% | 807M | |
+0.62% | 765M | |
-23.45% | 682M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories N.V. Approves A Cash Dividend, Payable on 30 May 2023